Standard
Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease. / Wanitschek, Maria; Pfisterer, Matthias; Hvelplund, Anders; De Servi, Stefano; Bertel, Osmund; Jeger, Raban; Rickenbacher, Peter; Iversen, Allan; Jensen, Jan Skov; Galatius, Soeren; Kaiser, Christoph; Alber, Hannes; Investigators, for the BASKET-PROVE.
I:
International Journal of Cardiology, Bind 168, Nr. 3, 2013, s. 2381–2388.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Wanitschek, M, Pfisterer, M, Hvelplund, A, De Servi, S, Bertel, O, Jeger, R, Rickenbacher, P, Iversen, A, Jensen, JS, Galatius, S, Kaiser, C, Alber, H & Investigators, FTBASKET-PROVE 2013, '
Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease',
International Journal of Cardiology, bind 168, nr. 3, s. 2381–2388.
https://doi.org/10.1016/j.ijcard.2013.01.257APA
Wanitschek, M., Pfisterer, M., Hvelplund, A., De Servi, S., Bertel, O., Jeger, R., Rickenbacher, P., Iversen, A., Jensen, J. S., Galatius, S., Kaiser, C., Alber, H., & Investigators, F. T. BASKET-PROVE. (2013).
Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease.
International Journal of Cardiology,
168(3), 2381–2388.
https://doi.org/10.1016/j.ijcard.2013.01.257Vancouver
Wanitschek M, Pfisterer M, Hvelplund A, De Servi S, Bertel O, Jeger R o.a.
Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease.
International Journal of Cardiology. 2013;168(3):2381–2388.
https://doi.org/10.1016/j.ijcard.2013.01.257Author
Wanitschek, Maria ; Pfisterer, Matthias ; Hvelplund, Anders ; De Servi, Stefano ; Bertel, Osmund ; Jeger, Raban ; Rickenbacher, Peter ; Iversen, Allan ; Jensen, Jan Skov ; Galatius, Soeren ; Kaiser, Christoph ; Alber, Hannes ; Investigators, for the BASKET-PROVE. / Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease. I: International Journal of Cardiology. 2013 ; Bind 168, Nr. 3. s. 2381–2388.
Bibtex
@article{95abbb9492fb47e7bc4adcc97644d260,
title = "Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease",
author = "Maria Wanitschek and Matthias Pfisterer and Anders Hvelplund and {De Servi}, Stefano and Osmund Bertel and Raban Jeger and Peter Rickenbacher and Allan Iversen and Jensen, {Jan Skov} and Soeren Galatius and Christoph Kaiser and Hannes Alber and Investigators, {for the BASKET-PROVE}",
year = "2013",
doi = "10.1016/j.ijcard.2013.01.257",
language = "English",
volume = "168",
pages = "2381–2388",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "3",
}
RIS
TY - JOUR
T1 - Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease
AU - Wanitschek, Maria
AU - Pfisterer, Matthias
AU - Hvelplund, Anders
AU - De Servi, Stefano
AU - Bertel, Osmund
AU - Jeger, Raban
AU - Rickenbacher, Peter
AU - Iversen, Allan
AU - Jensen, Jan Skov
AU - Galatius, Soeren
AU - Kaiser, Christoph
AU - Alber, Hannes
AU - Investigators, for the BASKET-PROVE
PY - 2013
Y1 - 2013
U2 - 10.1016/j.ijcard.2013.01.257
DO - 10.1016/j.ijcard.2013.01.257
M3 - Journal article
C2 - 23453439
VL - 168
SP - 2381
EP - 2388
JO - International Journal of Cardiology
JF - International Journal of Cardiology
SN - 0167-5273
IS - 3
ER -
